Decision Aid for Anomalous Aortic Origin of a Coronary Artery

The trial aims to create a decision aid for individuals with right anomalous aortic origin of a coronary artery (R-AAOCA), a condition where the coronary artery originates from the wrong side of the aorta. This tool assists patients, families, and doctors in making informed decisions about managing the condition, which can be stressful due to potential risks. The trial will compare the decision aid with standard care to determine if it improves decision-making comfort and quality of life. It is suitable for English-speaking individuals aged 10-35 diagnosed with R-AAOCA, who do not exhibit signs of restricted blood flow to the heart. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance decision-making for those with R-AAOCA.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

This trial tests a tool called a decision aid to help manage unusual blood vessel conditions in the heart, known as coronary artery anomalies. Research has shown that decision aids improve patients' understanding of treatment options and support informed choices with their doctors. They are generally safe, as they do not involve medication or surgery.

Researchers are excited about the Decision Aid for Anomalous Aortic Origin of a Coronary Artery because it offers a personalized approach to understanding coronary anomalies. Unlike the standard of care, which typically involves routine monitoring and generalized advice, this decision aid is designed to provide patients with tailored information, helping them better understand their condition and make informed decisions about their health. The hope is that this tool will empower patients and improve their quality of life by facilitating more effective communication between them and their healthcare providers.

Research has shown that decision aids in medical settings help patients make informed choices, especially when no single treatment is clearly superior. Studies have found that shared decision-making tools boost patient satisfaction and confidence in their medical decisions. In this trial, participants with right anomalous aortic origin of a coronary artery (R-AAOCA) will be divided into two groups: one receiving standard care and the other receiving standard care with a decision aid. While specific data on decision aids for R-AAOCA is still being gathered, existing evidence suggests these tools improve understanding and comfort in decision-making. Overall, decision aids empower patients to take an active role in their care, potentially enhancing their quality of life.¹³⁶⁷⁸